Established for more than six years, the Corporate Policy for the Eurofarma Fuel Consumption establishes the proportion of 75% ethanol and 25% gasoline to supply the cars from its fleet. The goal is to reduce the amount of CO2 emissions (the main cause of the greenhouse effect) and costs. Between 2009 and 2015, the measure enabled a 54% reduction in CO2 emission of the fleet.

Eurofarma is one of the only pharmaceutical businesses in the country to develop an inventory on the greenhouse gases in the industrial area. This is a fundamental step for the company to develop and improve domestic policies to reduce global pollutants, besides seeking Clean Development Mechanism projects (CDM). The study is performed according to the GHG Protocol methodology.